AQUIS STOCK EXCHANGE

Heart health products developer ProBiotix Health (PBX) interim revenues increased 53% to £2.06m and improved gross margins. There was a swing from a loss of £153,000 to a pre-tax profit of £79,000. The growth was in the US. There was a £19,000 cash outflow from operating activities during the period and £1.24m in cash at the end of June 2026. The growth was in the US and there are prospects of second half growth in Asia and Europe, as well as in the US.

Emissions reduction additives developer Sulnox Group (SNOX) increased first quarter revenues by 54% to £804,600. Volumes were 73% higher. Cash was £1.54m at the end of June 2026 with some of the £2m recently raised invested in increased inventories.

Ajax Resources (AJAX) has started the environmental permitting process for the maiden drilling at the Pereira Velho gold project in Brazil. The process could take three months. The drilling budget is $1.5m. There has already been $5m spent on drilling and other work. The new work will enable a maiden mineral resource estimate to be calculated.

Global Connectivity (GCON) raised £293,000 at 0.1p/share. This will provide working capital and should last until July 2027.

EPE Special Opportunities (EO.P) says it will not buyback any more shares for the time being. The interims will be published on 9 September.

Delta Gold Technologies (DGQ) director Jamie Tosh bought 20,000 shares at 122p each. He owns 5.7%. Delta Gold Technologies has raised £30,000 from an exercise of warrants at 15p each.

ASSET MATCH

Trading in brewer Wadworth and Co (WAD) shares is starting on the Asset Match PISCES platform. Interim sales increased 6% to £22.6m, while EBITDA improved 14% to £2.7m. Own beer sales were 8% ahead and this is helping margins of managed pubs. The World Cup helped the figures. Tenanted pubs income is flat. The current wine and spirits contract is due for renewal next year and options will be reviewed.

An independent valuation of the Valens Pay fintech platform business by Wills Capital indicates a range of $560m to $1.39bn. Valens Pay is the principal platform owned by VP Fintech (VPF).

AIM

Communications and satellite technology developer Filtronic (FTC) reported a small dip in revenues to £55.5m, despite adverse currency movements, and investment in technology and increasing capacity led to a fall in pre-tax profit from £15.1m to £8.1m. Additional engineering and business development staff have been taken on. The new Sedgefield facility is up and running and annual capacity has increased to more than £200m. SpaceX remains the largest customer, but new customers are diversifying revenues. Pre-tax profit is expected to rise to £8.9m this year and 95% of forecast revenues are in the order book. Early forecasts tend to be conservative so there is room for upgrades later in the year.

Video games developer Devolver Digital (DEVO) plans to cancel its AIM quotation and there will be a tender offer of up to $5m at 16p/share. Shareholders are being asked to approve the proposals at a general meeting on 8 September. A further tender offer of up to $5m is planned for 12 months after cancellation. There will be annual cost savings of $1.6m, and the board does not believe that the share price reflects the recent progress, partly due to poor liquidity. Devolver Digital joined AIM on 4 November 2021 at 157p/share

Wellnex Life Ltd (WNX) is selling its main brand Pain Away to Japan-based Rohto Pharmaceutical for up to A$21.3m. The initial cash payment of A$19.8m is payable on completion and will be used to repay debt and invest in the remaining healthcare and contract manufacturing activities. The remaining payment is dependent on performance in the 12 months after the purchase. Shareholder approval for the deal will be sought on 8 September. In 2024-25, Pain Away had revenues of A$13.4m and EBITDA of $4.36m. The rest of the business lost money. Wellnex Life raised £5.22m at 31.75p/share when it joined AIM on 21 March 2025.

Transport software and services provider Tracsis (TRCS) is selling non-core events operations for £7.3m. In 2024-25 revenues were £20.4m and EBITDA was £1.9m. This was expected to improve. This will lead to a net reduction in profit after the disposal, but management can concentrate on the core rail technology business, which has better margins.

Strategic communications company Aeorema Communications (AEO) says interim revenues should be one-third higher at £17.4m, and pre-tax profit could treble before forex movements to £1.5m. After the year end change, the first half is much stronger than the second half, where a loss is likely. Forecast full year revenues have been raised from £20.4m to £22m, while pre-tax profit is improved from £740,000 to £810,000.

Automotive interior components supplier CT Automotive (CTA) says revenues grew 15% to $62.1m in the first half. However, higher operating costs mean that profit will be much lower than in the first half of 2025. Some of the cost increase can be recovered but that has been delayed until the second half. Production inefficiencies in Mexico had to be rectified. Revenues and profit should be stronger in the second half, and the company is optimistic about achieving full year forecasts.

Furnishings supplier Sanderson Design Group (SDG) says interim revenues improved 6% to £51.4m thanks to a 19% increase in North American brand product revenues. Third-party manufacturing revenues recovered 19% to £11m. Licensing revenues were 13% higher at £4.9m. Net cash was £10.2m at the end of July 2026.

Cybersecurity services provider Corero Network Security (CNS) says interim revenues were 42% ahead at $15.5m and it made a positive EBITDA. Annualised recurring revenues are 12% higher at $24.1m. Cash is $2.1m. Zeus still expects a move back into profit for the full year with a pre-tax profit of $400,000 forecast. The broker will review its forecast when the interim results are published.

FIH Group (FIH) is selling the Momart art logistics business for £7.6m to a larger rival and the deal should complete by the end of September. Momart made a loss last year. There could be a cash distribution to shareholders, as well as investment in the remaining business in the Falkland Islands.

Hostels operator Safestay (SSTY) is selling its London Kensington Holland Park property for £3m. This is one of the company’s early sites and it generated revenues of £1.7m last year. There should be a £2.6m gain on the disposal. NAV was 22.2p/share at the end of 2025.

IP and content management Ingenta (ING) is acquiring 23.9% of FirstAida, which is an early-stage legalTech business that is involved in AI software that helps IP holders to identify copyright infringement. The cost is £500,000 in shares and there is an option to buy the rest at a price linked to performance. There is a small dilution to this year’s earnings because of the share issue.

Battery technology developer Gelion (GELN) has secured a joint development agreement with battery materials manufacturer Mitsui Kinzoku which will help progress towards commercial manufacturing in Asia. Gelion will receive £2m in staged payments to validate the company’s NES cathode active material (CAM) for use in high density liquid and solid-state sulfur battery cells. Mitsui Kinzoku has an option to negotiate manufacturing rights in some countries in Asia.

Kazera Global (KZG) says that the technical report for the Sea Concession 2A heavy mineral sands project in Alexander Bay, Northern Cape, South Africa shows an inferred mineral resource estimated at 6.65 million tonnes of heavy mineral sands at an approximate grade of 20%. This is principally garnet, ilmenite, zircon and rutile. This is based on 1.42% of the licence area.

ePharmacy company Vulcan Two (VUL) says integration of its three acquisitions is progressing well. Vulcan Two is shedding lower margin customers and focusing on profitability. Forecast 2026 revenues reduced by 4% to £38.9m and additional staff hires and duplicated running costs have cut the pre-tax profit forecast from £1.9m to £1.1m.

MAIN MARKET

Foams manufacturer Zotefoams (ZTF) grew interim revenues 23% to £95.2m and pre-tax profit was one-third higher at £15.3m. This included a full contribution from OKC, which was acquired late last year. Organic growth was 4%. This was achieved even though footwear sales were 23% lower. Underlying organic growth excluding footwear was 28%. This means that footwear is 30% of total sales, down from 48%.

North east England-based property finance and development company Develop North (DVNO) reported increased interim income of £1.27m, up from £1.04m. The total value of the portfolio is £22.9m. This covers 14 projects following two exits during the period. There were write downs on two projects unable meet interest obligations and this led to a first half loss. The total dividends are 2p/share so far this year. The NAV at the end of May 2026 was 74.8p/share.

Ground engineering and piling business Keller (KLR) grew interim revenues by 10% to £1.61bn, while underlying pre-tax profit improved from £92.7m to £108.7m. There was growth in all regions, and the order book is a record at £1.9bn. This stretches well into next year. Non-exec director Stephen King bought 6,500 shares at £30.62 each.

Solvonis Therapeutics (SVNS) says initial screeding data for SVN-015 is encouraging. This is an AI discovered stimulant use disorder candidate. The next stage of evaluation is funded by the US National Institute on Drug Abuse. Solvonis retains full ownership.

Andrew Hore